[
  {
    "ts": "2025-09-09T21:45:02+00:00",
    "headline": "Bristol Myers Squibb (BMY) Outperforms Broader Market: What You Need to Know",
    "summary": "In the latest trading session, Bristol Myers Squibb (BMY) closed at $47.23, marking a +1.09% move from the previous day.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-outperforms-214502756.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "fdb98a20-1dde-3a7f-af13-9895f1e04c8f",
      "content": {
        "id": "fdb98a20-1dde-3a7f-af13-9895f1e04c8f",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb (BMY) Outperforms Broader Market: What You Need to Know",
        "description": "",
        "summary": "In the latest trading session, Bristol Myers Squibb (BMY) closed at $47.23, marking a +1.09% move from the previous day.",
        "pubDate": "2025-09-09T21:45:02Z",
        "displayTime": "2025-09-09T21:45:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uV6mPOIlsfK8Kl7nmlunJw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc4z8_.3guA7NR27rd8O3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-outperforms-214502756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-outperforms-214502756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-09T17:17:00+00:00",
    "headline": "SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study",
    "summary": "Summit Therapeutics plunges 25% after its HARMONi study shows sharp regional differences in lung cancer trial outcomes.",
    "url": "https://finance.yahoo.com/news/smmt-stock-plummets-25-regional-171700392.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "55e16a3c-101d-3a91-880b-b19e9b2ebfc6",
      "content": {
        "id": "55e16a3c-101d-3a91-880b-b19e9b2ebfc6",
        "contentType": "STORY",
        "title": "SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study",
        "description": "",
        "summary": "Summit Therapeutics plunges 25% after its HARMONi study shows sharp regional differences in lung cancer trial outcomes.",
        "pubDate": "2025-09-09T17:17:00Z",
        "displayTime": "2025-09-09T17:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/smmt-stock-plummets-25-regional-171700392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/smmt-stock-plummets-25-regional-171700392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-09T14:15:32+00:00",
    "headline": "Idiopathic pulmonary fibrosis breakthroughs may lead to first drug approval in years",
    "summary": "Nerandomilast now leads the pipeline after demonstrating significant slowing of lung function decline in trials.",
    "url": "https://www.clinicaltrialsarena.com/analyst-comment/breakthroughs-idiopathic-pulmonary-fibrosis/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "b928bb28-e302-3753-a15b-233b88bb9dfd",
      "content": {
        "id": "b928bb28-e302-3753-a15b-233b88bb9dfd",
        "contentType": "STORY",
        "title": "Idiopathic pulmonary fibrosis breakthroughs may lead to first drug approval in years",
        "description": "",
        "summary": "Nerandomilast now leads the pipeline after demonstrating significant slowing of lung function decline in trials.",
        "pubDate": "2025-09-09T14:15:32Z",
        "displayTime": "2025-09-09T14:15:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/d42e4e478407f68c7bc5e436b86d0718",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "New drugs potentially reaching approval in 2025 may bring hope to multiple patients. Credit: SkazovD via Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kqMVhOycQREUdGvXl5mo5Q--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/d42e4e478407f68c7bc5e436b86d0718.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fcZpL.RJqGjPks_lZLbXWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/d42e4e478407f68c7bc5e436b86d0718.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/analyst-comment/breakthroughs-idiopathic-pulmonary-fibrosis/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/idiopathic-pulmonary-fibrosis-breakthroughs-may-141532475.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-09T10:05:00+00:00",
    "headline": "The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now",
    "summary": "With a 6.2% yield, this high yielder is focused on supporting the innovation that drives the healthcare industry forward.",
    "url": "https://www.fool.com/investing/2025/09/09/the-best-ultra-high-yield-dividend-stock-to-invest/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a05419e6-f150-3d15-bcdf-171b7fd894a5",
      "content": {
        "id": "a05419e6-f150-3d15-bcdf-171b7fd894a5",
        "contentType": "STORY",
        "title": "The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now",
        "description": "",
        "summary": "With a 6.2% yield, this high yielder is focused on supporting the innovation that drives the healthcare industry forward.",
        "pubDate": "2025-09-09T10:05:00Z",
        "displayTime": "2025-09-09T10:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/80cd4cdc9ee9cf62d6e27782889600b5",
          "originalWidth": 1200,
          "originalHeight": 633,
          "caption": "A scientist working with a flask and beaker.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GX3lQ1Ug3jxgYRs6Nfew8w--~B/aD02MzM7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/80cd4cdc9ee9cf62d6e27782889600b5.cf.webp",
              "width": 1200,
              "height": 633,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/31j8k96BVSpAcnHyQIzH4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/80cd4cdc9ee9cf62d6e27782889600b5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/09/the-best-ultra-high-yield-dividend-stock-to-invest/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-ultra-high-yield-dividend-100500087.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "ARE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]